References
- Dickson DW. Neuropathology of Parkinson disease. Parkinsonism Relat Disord. 2018;46(1):S30–S33. http://dx.doi.org/10.1016/j.parkreldis2017.07.033
- National Health Service (NHS). Parkinson’s disease – Symptoms – NHS [Internet]. Health A-Z. 2016 [cited 2018 Oct 2]. p. 1. Available from: https://www.nhs.uk/conditions/parkinsons-disease/symptoms/
- Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention [Internet]. Vol. 15. 2016 [cited 2018 Oct 2]. Available from: www.thelancet.com/neurology
- Kalia LV, Lang AE. Parkinson’s disease. Lancet [Internet]. 2015;386(9996):896–912. http://dx.doi.org/10.1016/
- National Health Service (NHS). Parkinson’s disease – NHS [Internet]. Health A-Z. 2016. [cited 2018 Oct 2]. Available from: https://www.nhs.uk/conditions/parkinsons-disease/
- Schapira A. Science, medicine, and the future: Parkinson's disease. BMJ. 1999;318(7179):311–314.
- Kakinuma S, Nogaki H, Pramanik B, et al. Muscle weakness in Parkinson's disease: isokinetic study of the lower limbs. Eur Neurol. 1998;39(4):218–222. [cited 2018 Oct 3]Available from: http://biomednet.com/karger
- Johnell O, Melton LJ, Atkinson EJ, et al. Fracture risk in patients with Parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing. 1992;21(1):32–38.
- Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. J Am Med Assoc. 2014;311(16):1670–1683.
- Ellis JM, Fell MJ. Current approaches to the treatment of Parkinson's disease. Bioorg Med Chem Lett. 2017;27(18):4247–4255.
- Rogers G, Davies D, Pink J, et al. Parkinson's disease: summary of updated NICE guidance. BMJ. 2017;358:j1951. [cited 2018 Feb 6] Available from: http://www.ncbi.nlm.nih.gov/pubmed/28751362
- Parkinsons UK. Side effects of Parkinson’s drugs | Parkinson’s UK [Internet]. [cited 2018 Oct 3]. Available from: https://www.parkinsons.org.uk/information-and-support/side-effects-parkinsons-drugs
- Aquino CC, Fox SH. Clinical spectrum of levodopa-induced complications. Mov Disord. 2015;30(1):80–89. Jan
- Borrione P, Tranchita E, Sansone P, et al. Effects of physical activity in Parkinson's disease: a new tool for rehabilitation. World J Methodol. 2014;4(3):133–143.
- Paillard T, Rolland Y, Souto Barreto P. Protective effects of physical exercise in Alzheimer's disease and Parkinson's disease: a narrative review. J Clin Neurol. 2015;11(3):212–219. http://dx.doi.org/10.3988/jcn.2015.11.3.212
- Falvo MJ, Schilling BK, Earhart GM. Parkinson's disease and resistive exercise: rationale, review, and recommendations. Mov Disord. 2008;23(1):1–11. http://doi.wiley.com/10.1002/mds.21690
- Lau C, Chung H, Thilarajah S, et al. Effectiveness of resistance training on muscle strength and physical function in people with Parkinson’s disease: a systematic review and meta-analysis. Clin Rehabil. 2016;30(1):11–23. http://journals.sagepub.com/doi/pdf/10.1177/0269215515570381
- Lima LO, Scianni A, Rodrigues-de-Paula F. Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson’s disease: a systematic review. J Physiother. 2013;59(1):7–13. https://www.sciencedirect.com/science/article/pii/S1836955313701413
- Roeder L, Costello JT, Smith SS, Stewart IB, et al. Effects of resistance training on measures of muscular strength in people with Parkinson's disease: a systematic review and meta-analysis. PLoS One. 2015;10(7):e0132135. http://www.ncbi.nlm.nih.gov/pubmed/26146840
- David FJ, Rafferty MR, Robichaud JA, et al. Progressive resistance exercise and Parkinson's disease: a review of potential mechanisms. Parkinsons Dis. 2012;2012:124527. http://www.ncbi.nlm.nih.gov/pubmed/22191068
- PD Warrior. PD Warrior [Internet]. 2017. [cited 2018 Oct 7]. Available from: https://pdwarrior.com/
- Lang AE, Espay AJ. Disease modification in Parkinson's disease: current approaches, challenges, and future considerations. Mov Disord. 2018;33(5):660–677. http://doi.wiley.com/10.1002/mds.27360
- Petzinger GM, Fisher BE, Van Leeuwen J-E, et al. Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson’s disease. Mov Disord. 2010;25(S1):S141–S145. http://doi.wiley.com/10.1002/mds.22782
- American College of Sports Medicine. ACSM’s exercise management for persons with chronic diseases and disabilities. In: Moore G, Durstine J, Painter P, editors. Champaign, IL: Human kinetics. 4th ed; 2016. 416 p.
- American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. 9th rev. Kluwer W, editor. Philadelphia (PA): Lippincott Williams & Wilkins; 2013, 480 p.
- American College of Sports Medicine. ACSM’s resource manual for guidelines and exercise testing and prescription. 7th ed. Kluwer W, editor. Philadelphia (PA): Lippincott Williams & Wilkins; 2013, 896 p.
- CASP UK. CASP – Critical Appraisal Skills Programme [Internet]. Critical Appraisal Skills Programme. 2018 [cited 2018 Apr 20]. p. 1. Available from: https://casp-uk.net/.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement David Moher and colleagues introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses. 2009. [cited 2018 Dec 7]. Available from: http://www.bmj.com/content/339/bmj.b2535?tab=related#datasupp
- Alessandro Carvalho A, Barbirato D, Santos T, et al. Comparison of strength training, aerobic training, and additional physical therapy as supplementary treatments for Parkinson’s disease: pilot study. Clin Interv Aging. 2015;10:183. Available from: http://www.dovepress.com/comparison-of-strength-training-aerobic-training-and-additional-physic-peer-reviewed-article-CIA
- Demonceau M, Maquet D, Jidovtseff B, et al. Effects of twelve weeks of aerobic or strength training in addition to standard care in Parkinson’s disease: a controlled study. Eur J Phys Rehabil Med. 2016;52(2):184–200.
- Morris ME, Menz HB, McGinley JL, et al. A randomized controlled trial to reduce falls in people with Parkinson’s disease. Neurorehabil Neural Repair. 2015;29(8):777–785. http://journals.sagepub.com/doi/10.1177/1545968314565511
- Ni M, Signorile JF, Balachandran A, et al. Power training induced change in bradykinesia and muscle power in Parkinson’s disease. 2016. [cited 2018 Oct 20]; Available from: http://dx.doi.org/10.1016/j.parkreldis.2015.11.028
- Shulman LM, Katzel LI, Ivey FM, et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol. 2013;70(2):183. http://archneur.jamanetwork.com/article.aspx?doi=10.1001/jamaneurol.2013.646
- Paul SS, Canning CG, Song J, et al. Leg muscle power is enhanced by training in people with Parkinson’s disease: a randomized controlled trial Article. Clin Rehabil. 2014;28(3):275–288. http://0-journals.sagepub.com.serlib0.essex.ac.uk/doi/pdf/10.1177/0269215513507462
- Dibble LE, Hale TF, Marcus RL, et al. High intensity eccentric resistance training decreases bradykinesia and improves quality of life in persons with Parkinson’s disease: a preliminary study q. 2009. [cited 2018 Oct 20]. Available from: https://0-ac-els–cdn-com.serlib0.essex.ac.uk/S1353802009001138/1-s2.0-S1353802009001138-main.pdf?_tid=80016521-a8f6-4f24-877f-b5421f804085&acdnat=1540058077_1918257fdbf93ad3fe14c9cfa70858e6
- Hass CJ, Buckley TA, Pitsikoulis C, et al. Progressive resistance training improves gait initiation in individuals with Parkinson's disease. Gait Posture. 2012;35(4):669–673. http://linkinghub.elsevier.com/retrieve/pii/S0966636211008381
- Peacock CA, Sanders GJ, Wilson KA, et al. Introducing a multifaceted exercise intervention particular to older adults diagnosed with Parkinson's disease: a preliminary study. Aging Clin Exp Res. 2014;26(4):403–409.
- Dibble LE, Hale TF, Marcus RL, et al. High-intensity resistance training amplifies muscle hypertrophy and functional gains in persons with Parkinson’s disease. Mov Disord. 2006;21(9):1444–1452. http://doi.wiley.com/10.1002/mds.20997
- Corcos DM, Robichaud JA, David FJ, et al. A two-year randomized controlled trial of progressive resistance exercise for Parkinson’s disease. Mov Disord. 2013;28(9):1230–1240. http://doi.wiley.com/10.1002/mds.25380
- Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17(5):427–442. http://n.neurology.org/content/neurology/17/5/427.full.pdf
- Breteler MMB, Manubens-Bertran JM, De Rijk MC, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the Europarkinson Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62(1):10–15. http://jnnp.bmj.com/
- Hirsch L, Jette N, Frolkis A, et al. The incidence of Parkinson’s disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46(4):292–300. http://www.ncbi.nlm.nih.gov/pubmed/27105081
- National Institute for Health and Care Excellence (NICE). Parkinson’s disease in adults: diagnosis and management [Internet]. 2017. [cited 2018 Oct 1]. Available from: https://www.nice.org.uk/guidance/ng71/evidence/full-guideline-pdf-4538466253
- Riebe D, Ehrman JK, Liguori G, et al. ACSM’s guidelines for exercise testing and prescription. Tenth Edit. Wolters Kluwer; 2018. 472 p.
- Durstine JL, Moore GE, Painter PL, American College of Sports Medicine. ACSM’s exercise management for persons with chronic diseases and disabilities. 4th ed. Champaign, IL: Human Kinetics; 2016;391 p.
- Hackshaw A. Small studies: strengths and limitations [cited 2019 Feb 21]; Available from: https://erj.ersjournals.com/content/erj/32/5/1141.full.pdf
- Age UK. Falls in the over 65s cost NHS £4.6 million a day [Internet]. Ageuk. 2010. [cited 2018 Dec 24]. p. 1. Available from: https://www.ageuk.org.uk/latest-press/archive/falls-over-65s-cost-nhs/#
- Schrag A, Selai C, Jahanshahi M, et al. The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2000;69(1):67–73. http://jnnp.bmj.com/
- Park H-J, Sohng K-Y, Kim S. Validation of the Korean version of the 39-Item Parkinson's Disease Questionnaire (PDQ-39). Asian Nurs Res (Korean Soc Nurs Sci). 2014;8(1):67–74. http://www.ncbi.nlm.nih.gov/pubmed/25030495
- Zhang J-L, Chan P. Reliability and validity of PDQ-39: a quality-of-life measure for patients with PD in China (Abstract). Qual Life Res. 2012;21(7):1217–1221. http://link.springer.com/10.1007/s11136-011-0026-1
- Tan LCS, Luo N, Nazri M, et al. Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson’s disease patients in Singapore. Parkinsonism Relat Disord. 2004;10(8):493–499. https://www.sciencedirect.com/science/article/pii/S1353802004000999
- Dehghan A, Ghaem H, Borhani-Haghighi A, et al. Evaluation of reliability and validity of PDQ-39: questionnaire in Iranian patients with Parkinson’s disease. Zahedan J Res Med Sci. 2016;18(3):29–33. http://zjrms.com/en/articles/6245.html
- Damiano AM, Snyder C, Strausser B, et al. A review of health-related quality-of-life concepts and measures for Parkinson’s disease. (Abstract). Qual Life Res. 1999;8(3):235–243. http://www.ncbi.nlm.nih.gov/pubmed/10472154